Short-Term Effect of Botulinum Toxin A Injection on Spastic Equinovarus Foot in Cerebral Palsy Patients: A Study Using the Foot Pressure Measurement System
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective To evaluate the therapeutic effect of botulinum toxin A (BTX-A) injection on spastic gastrocnemius (GCM) and tibialis posterior muscles (TPo) by using the foot pressure measurement system (FPMS).Methods Eighteen ambulatory CP patients were recruited in this study. BTX-A was injected into the GCM at a dose of 6–12 units/kg and TPo at a dose of 4–9 units/kg according to the severity of equinus and varus deformity. Foot contact pattern, pressure time integral (PTI), coronal index using the FPMS and Modified Ashworth Scale (MAS), and visual inspection of gait pattern were used for evaluation of the therapeutic effect of BTX-A injection. Clinical and FPMS data were statistically analyzed according to the muscle group.Results A significant decrease in the MAS score of the GCM and TPo was observed, and spastic equinovarus pattern during gait showed improvement after injection. The GCM+TPo injection group showed a significant decrease in forefoot, lateral forefoot pad, and lateral column PTI, and a significant increase in hindfoot PTI and coronal index. In the GCM only injection group, forefoot PTI and lateral column PTI were significantly decreased and hindfoot PTI was significantly increased. The TPo only injection group showed a significant decrease in lateral column PTI and a significant increase in the coronal index. Change in PTI in the hindfoot showed a significant correlation with the change in MAS score of the GCM. Change in PTI of the lateral column and coronal index showed a significant correlation with the change in MAS score of the TPo. Conclusion The FPMS demonstrated the quantitative therapeutic effect of BTX-A on abnormal pressure distribution in equinovarus foot in detail. The FPMS can be a useful additional tool for evaluation of the effect of BTX-A injection.
Abstract
Objective To evaluate the therapeutic effect of botulinum toxin A (BTX-A) injection on spastic gastrocnemius (GCM) and tibialis posterior muscles (TPo) by using the foot pressure measurement system (FPMS).Methods Eighteen ambulatory CP patients were recruited in this study. BTX-A was injected into the GCM at a dose of 6–12 units/kg and TPo at a dose of 4–9 units/kg according to the severity of equinus and varus deformity. Foot contact pattern, pressure time integral (PTI), coronal index using the FPMS and Modified Ashworth Scale (MAS), and visual inspection of gait pattern were used for evaluation of the therapeutic effect of BTX-A injection. Clinical and FPMS data were statistically analyzed according to the muscle group.Results A significant decrease in the MAS score of the GCM and TPo was observed, and spastic equinovarus pattern during gait showed improvement after injection. The GCM+TPo injection group showed a significant decrease in forefoot, lateral forefoot pad, and lateral column PTI, and a significant increase in hindfoot PTI and coronal index. In the GCM only injection group, forefoot PTI and lateral column PTI were significantly decreased and hindfoot PTI was significantly increased. The TPo only injection group showed a significant decrease in lateral column PTI and a significant increase in the coronal index. Change in PTI in the hindfoot showed a significant correlation with the change in MAS score of the GCM. Change in PTI of the lateral column and coronal index showed a significant correlation with the change in MAS score of the TPo. Conclusion The FPMS demonstrated the quantitative therapeutic effect of BTX-A on abnormal pressure distribution in equinovarus foot in detail. The FPMS can be a useful additional tool for evaluation of the effect of BTX-A injection.
참고문헌 (38)
- Park ES, "Dynamic foot pressure measurements for assessing foot deformity in persons with spastic cerebral palsy", Arch Phys Med Rehabil, 87, pp.703~709 (2006)
- Chang CH, "Dynamic pedobarograph in evaluation of varus and valgus foot deformities", J Pediatr Orthop, 22, pp.813~818 (2002)
- Tylkowski CM, "Outcomes of gastrocnemius-soleus complex lengthening for isolated equinus contracture in children with cerebral palsy", J Pediatr Orthop, 29, pp.771~778 (2009)
- Oddy MJ, "Botulinum toxin injection site localization for the tibialis posterior muscle", J Pediatr Orthop B, 15, pp.414~417 (2006)
- Mayer NH, "Common patterns of clinical motor dysfunction", Muscle Nerve Suppl, 6, pp.S21~S35 (1997)
- Molteni F, "Gait analysis", pp.263~286 (2002), Hanley & Belfus
- Bollens B, "A randomized controlled trial of selective neurotomy versus botulinum toxin for spastic equinovarus foot after stroke", Neurorehabil Neural Repair, 27, pp.695~703 (2013)
- Park CI, "Effects of botulinum toxin A therapy on gastrocnemius in spastic cerebral palsied children", J Korean Acad Rehabil Med, 23, pp.504~515 (1999)
- Koman LA, "Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebocontrolled trial. BOTOX Study Group", J Pediatr Orthop, 20, pp.108~115 (2000)
- Riad J, "Reliability of pediobarographs for paediatric foot deformity", J Child Orthop, 1, pp.307~312 (2007)
- Armstrong DG, "Plantar pressures are higher in diabetic patients following partial foot amputation", Ostomy Wound Manag, 44, pp.30~32 (1998)
- Armstrong DG, "Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration?", J Foot Ankle Surg, 37, pp.303~307 (1998)
- Holmes GB Jr, "A quantitative assessment of the effect of metatarsal pads on plantar pressures", Foot Ankle, 11, pp.141~145 (1990)
- Lavery LA, "Predictive value of foot pressure assessment as part of a population-based diabetes disease management program", Diabetes Care, 26, pp.1069~1073 (2003)
- Minns RJ, "Pressure under the forefoot in rheumatoid arthritis: a comparison of static and dynamic methods of assessment", Clin Orthop Relat Res, 187, pp.235~242 (1984)
- Singh N, "Preventing foot ulcers in patients with diabetes", JAMA, 293, pp.217~228 (2005)
- Oeffinger DJ, "Foot pressure and radiographic outcome measures of lateral column lengthening for pes planovalgus deformity", Gait Posture, 12, pp.189~195 (2000)
- Liggio FJ, "Split tibialis posterior tendon transfer with concomitant distal tibial derotational osteotomy in children with cerebral palsy", J Pediatr Orthop, 21, pp.95~101 (2001)
- 박은숙, "경직형 뇌성마비에서 족저압 측정을 이용한 첨족 변형 교정 수술의 평가", Annals of Rehabilitation Medicine, 29(5), pp.507~512 (2005), 대한재활의학회
- 박은숙, "경직형 뇌성마비 환아의 보행 시 족저압 분포 및 족저압 중심의 이동경로", Annals of Rehabilitation Medicine, 26(2), pp.127~132 (2002), 대한재활의학회
- Chang CH, "Longterm follow-up of surgery for equinovarus foot deformity in children with cerebral palsy", J Pediatr Orthop, 22, pp.792~799 (2002)
- Huber H, "Dynamic foot-pressure measurement in the assessment of operatively treated clubfeet", J Bone Joint Surg Am, 86A, pp.1203~1210 (2004)
- Metaxiotis D, "Dynamic pedobarography (DPB) in operative management of cavovarus foot deformity", Foot Ankle Int, 21, pp.935~947 (2000)
- Boulay C, "Dynamic EMG of peroneus longus in hemiplegic children with equinovarus", Ann Phys Rehabil Med, 57, pp.185~192 (2014)
- Ben-Shabat E, "Intra- and interrater reliability of the Modified Tardieu Scale for the assessment of lower limb spasticity in adults with neurologic injuries", Arch Phys Med Rehabil, 94, pp.2494~2501 (2013)
- Papavasiliou AS, "Botulinum toxin treatment in upper limb spasticity: treatment consistency", Eur J Paediatr Neurol, 16, pp.237~242 (2012)
- Baker R, "Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, doseranging study", Dev Med Child Neurol, 44, pp.666~675 (2002)
- Colovic H, "Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 156, pp.41~47 (2012)
- Degelaen M, "Influence of botulinum toxin therapy on postural control and lower limb intersegmental coordination in children with spastic cerebral palsy", Toxins (Basel), 5, pp.93~105 (2013)
- Bakheit AM, "Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity", Dev Med Child Neurol, 43, pp.234~238 (2001)
- 이숙정, "The Effect and Complication of Botulinum Toxin Type A Injection with Serial Casting for the Treatment of Spastic Equinus Foot", Annals of Rehabilitation Medicine, 35(3), pp.344~353 (2011), 대한재활의학회
- Falso M, "Pedobarometric evaluation of equinus foot disorder after injection of botulinum toxin A in children with cerebral palsy: a pilot study", Dev Med Child Neurol, 47, pp.396~402 (2005)
- Bowen TR, "A method of dynamic foot-pressure measurement for the evaluation of pediatric orthopaedic foot deformities", J Pediatr Orthop, 18, pp.789~793 (1998)
- Chang CH, "Longterm follow-up of surgery for equinovarus foot deformity in children with cerebral palsy", J Pediatr Orthop, 22, pp.792~799 (2002)
- Davitt JS, "Plantar pressure and radiographic changes after distal calcaneal lengthening in children and adolescents", J Pediatr Orthop, 21, pp.70~75 (2001)
- Sutherland DH, "Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy", Gait Posture, 10, pp.1~9 (1999)
- Koog YH, "Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review", Clin Rehabil, 24, pp.685~700 (2010)
- Bottos M, "Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment", Dev Med Child Neurol, 45, pp.758~762 (2003)
